BIOMAT Database Logo BIOMAT Database Logo

Nursing care management of photodynamic therapy in digestive tract carcinomas at a single cancer center. 2017

Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Center for Digestive Disease, Faculty of Medicine, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki, Miyazaki, 8891692, Japan. Electronic address: a_nanashima@med.miyazaki-u.ac.jp.

The primary goal of nursing care in cases of endoscopic photodynamic therapy (PDT) for digestive tract carcinoma is to prevent phototoxicity by the intravenous administration of photosensitizers. The adequate protocol and management of patients should be conducted under the instruction of expert physicians. Our experiences of administering porfimer sodium and talaporfin sodium during clinical PDT provide insight regarding the specific management protocol of each photosensitizer during an in-hospital stay. We herein report our nursing protocol based on 15 years of experience. Under adequate management, PDT can be safely performed.

UI MeSH Term Description Entries
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D002173 Cancer Care Facilities Institutions specializing in the care of cancer patients. Hospitals, Cancer,Cancer Care Facility,Cancer Hospital,Cancer Hospitals,Facilities, Cancer Care,Facility, Cancer Care,Hospital, Cancer
D002985 Clinical Protocols Precise and detailed plans for the study of a medical or biomedical problem and/or plans for a regimen of therapy. Protocols, Clinical,Research Protocols, Clinical,Treatment Protocols,Clinical Protocol,Clinical Research Protocol,Clinical Research Protocols,Protocol, Clinical,Protocol, Clinical Research,Protocols, Clinical Research,Protocols, Treatment,Research Protocol, Clinical,Treatment Protocol
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017319 Photosensitizing Agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. Photosensitizer,Photosensitizers,Photosensitizing Agent,Photosensitizing Effect,Photosensitizing Effects,Agent, Photosensitizing,Agents, Photosensitizing,Effect, Photosensitizing,Effects, Photosensitizing
D017323 Dihematoporphyrin Ether The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States. DHP Ether,Porfimer,Dihematoporphyrin Ester,Photofrin,Photofrin II,Porfimer Sodium,Ether, Dihematoporphyrin

Related Publications

Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
[Photodynamic therapy in oncological digestive tract surgery].
November 1991, Presse medicale (Paris, France : 1983),
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Management of prenatal nursing care at a Health Center in Angola.
February 2019, Revista brasileira de enfermagem,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Current status of photodynamic therapy in digestive tract carcinoma in Japan.
February 2015, International journal of molecular sciences,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas.
January 2008, Journal of hepato-biliary-pancreatic surgery,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Outcomes of the management of corrosive injuries of the upper digestive tract in a tertiary care center.
March 2022, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
[Medications and nursing care for the digestive tract].
June 1966, Les cahiers du nursing,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Photodynamic therapy for biliary tract cancer.
March 2009, The British journal of surgery,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Post-Pandemic Burden of COVID-19-Related Restrictions in the Management of Digestive Tract Cancers: A Single Center Study.
March 2024, Healthcare (Basel, Switzerland),
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Evolving management of upper-tract transitional-cell carcinoma at a tertiary-care center.
September 2002, Journal of endourology,
Atsushi Nanashima, and Koji Nakashima, and Hiroshi Kawakami, and Shinya Ashizuka, and Yoshimasa Kubota
Chemotherapy of carcinomas of the digestive tract.
January 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
Copied contents to your clipboard!